Targretin
bexarotene
Lymphoma, T-Cell, Cutaneous
Date of authorisation:
Revision: 23
Last updated:
MedicineHumanAuthorised
Retinoid-containing medicinal products - referral
acitretin
adapalene
alitretinoin
bexarotene
isotretinoin
tretinoin
tazarotene
Article 31 referrals
Associated names:
Panretin
Targretin
Status: European Commission final decision
Opinion/position date:
EC decision date:
Last updated:
ReferralHuman
EMEA-000892-PIP01-10 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Dermatology
PIP number: P/160/2010
Route(s) of administration: Cutaneous use
Pharmaceutical form(s):
Gel
Decision date:
Last updated:
Compliance check: ✔
PIPHuman
P/87/2010 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Dermatology
PIP number: P/87/2010
Route(s) of administration: Cutaneous use
Pharmaceutical form(s):
Solution
Decision date:
Last updated:
Compliance check: ✖
PIPHuman